Filter By
Clear all Advanced
I am/have/had
added new label for I am/have/had
more
I am looking for
added new label for I am looking for
more
Advanced Filters
Found 52 clinical trials
Daratumumab-bortezomib-dexamethasone (Dara-VCd) vs Bortezomib-Thalidomide-Dexamethasone (VTd) Then Maintenance With Ixazomib (IXA) or IXA-Dara

-VCd) versus the association of bortezomib, thalidomide and dexamethasone (VTd) as pre transplant induction and post transplant consolidation, followed by maintenance with ixazomib alone or in

plasmacytoma
calcium
immunohistochemistry
granulocyte colony stimulating factor
platelet count
  • 60 views
  • 27 Aug, 2021
  • 5 locations
Antiangiogenic Therapy for Children With Recurrent Medulloblastoma Ependymoma and ATRT

endothelial cells, and minimizes toxicity. In this study the investigators will evaluate the use of biweekly intravenous bevacizumab in combination with five oral drugs (thalidomide, celecoxib, fenofibrate

ependymoma
karnofsky performance status
combinations
bevacizumab
medulloblastoma
  • 40 views
  • 17 Sep, 2021
  • 27 locations
An Efficacy and Safety Study of Luspatercept (ACE-536) Versus Placebo in Subjects With Myeloproliferative Neoplasm-Associated Myelofibrosis on Concomitant JAK2 Inhibitor Therapy and Who Require Red Blood Cell Transfusions

The purpose of this Phase 3 study is to evaluate the efficacy and safety of Luspatercept compared with placebo in subjects with myeloproliferative neoplasm (MPN)-associated Myelofibrosis (MF) and anemia on concomitant Janus kinase 2 (JAK2) inhibitor therapy and who require red blood cell count (RBC) transfusions. The study is divided …

cancer
vasectomy
bilateral oophorectomy
anemia
  • 0 views
  • 29 Aug, 2021
  • 159 locations
Thalidomide Plus Peginterferon and Ribavirin in Patients With Interferon Resistance

thalidomide in combination with peginterferon and ribavirin. DESIGN OF TEST Pilot Study: The single arm study will: 1. Thalidomide 200 mg and peg-interferon alfa 2b (based on

peginterferon
ribavirin
chronic hepatitis
liver disease
interferon
  • 6 views
  • 07 Nov, 2020
  • 1 location
Adjuvant Therapy With Thalidomide After Curative Resection of Hepatocellular Carcinoma

effective in preventing or delaying recurrence. The aim of this prospective randomized study was to evaluate the effectiveness of Thalidomide as a postoperative adjuvant regimen in inhibiting the

thalidomide
TACE
  • 6 views
  • 08 Nov, 2020
  • 1 location
TPM Regimen (Thalidomide Prednisone and Methotrexate) in LGLL

are indolent disease and share similar biology and clinical course, and treated under the same strategy. So the investigators put them together as LGLL. The investigators used TPM regimen (thalidomide

lymphoid leukemia
  • 0 views
  • 24 Jan, 2021
  • 9 locations
A Clinical Study to Test the Effects of Ruxolitinib And Thalidomide Combination for Patients With Myelofibrosis

The purpose of this study is to test any good and bad effects of the study drugs called ruxolitinib and thalidomide. Ruxolitinib and thalidomide could shrink the cancer, but it could also cause

cancer
ruxolitinib
polycythemia
  • 198 views
  • 03 Feb, 2021
  • 8 locations
Low-Dose Thalidomide as Adjuvant Therapy After Radiofrequency Ablation for Hepatocellular Carcinoma

The purpose of the investigators' study is to prospectively evaluate whether low-dose thalidomide adjuvant therapy will improve the outcome of radiofrequency ablation for hepatocellular

carcinoma
platelet count
hepatectomy
thalidomide
radiofrequency ablation
  • 3 views
  • 07 Nov, 2020
  • 1 location
Pyrotinib Plus Thalidomide in Advanced NSCLC Patients Harboring HER2 Exon 20 Insertions

combined with thalidomide in advanced non-small-cell lung cancer patients with HER2 exon 20 insertions.

  • 0 views
  • 03 Feb, 2021
  • 1 location
Thalidomide Cyclophosphamide and Dexamethasone for Recurrent/Refractory Adult Langerhans Cell Histiocytosis

treatment tends to show higher toxicity.There is little data to guide therapy after frontline treatment. In a phase 2 trial, thalidomide as monotherapy gave a 70% response rate in recurrent/refractory low

  • 0 views
  • 16 Jun, 2021
  • 1 location